Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan March 11, 2026 Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually.
Forbes 40th Annual World’s Billionaires List March 10, 2026 Elon Musk Is World’s Richest Person Ever Recorded
Language Weaver Brings Secure AI Translation Directly Into iManage Work Legal Workflows March 10, 2026 Secure multilingual content management gives legal firms competitive edge
Octus Unveils a Unified CreditAI Experience: The First-Ever, Compliance-Ready Generative AI Search for Both Public and Private Data Targeted Specifically for the Global Credit Markets March 10, 2026 New unified CreditAI is built on 12+ years of proprietary intelligence and data
Tech Startup Hosel Takes Swing at Global Second-Hand Golf Equipment Market March 10, 2026 Pre-owned golf club and equipment market valued at $3 billion Growing trend for golfers seeking “nearly new” clubs, as resale becomes increasingly core in retail Ascension VC leads pre-seed £500,000 investment, with further institutional round and US expansion planned this year Co-founder Andrew McGinley previously founded, scaled and exited care marketplace Care Sourcer, before going on to support hundreds of founders across the Scottish tech ecosystem
Reply: a New Study Shows that Agentic AI will Become a Strategic Alternative to Traditional Sourcing Models for 93% of Tech Leaders March 10, 2026 Reply [EXM, STAR: REY] today announced the release of “From Code to Control: AI’s Takeover of Software Development Lifecycle”, a commissioned study conducted by Forrester Consulting. The research, which surveyed 536 IT Executives across Europe and the US, highlights the progressive transition from simple AI coding assistants to autonomous agents capable of orchestrating the entire [...]
Spring into Smarter Home Protection: EZVIZ Launches Standout Deals for the Amazon Spring Sale March 10, 2026 As the new season brings longer days and fresh beginnings, EZVIZ is turning up the excitement with a lineup of irresistible offers during the Amazon Spring Sale. Known for delivering easy-to-use smart security products, EZVIZ is giving households the perfect opportunity to refresh their home protection with technology designed for modern living. This press release [...]
Bregal Sphere and Imperative Partner With Ambition to Deploy up to $500 Million Into Global Nature Restoration Projects March 10, 2026 Bregal Sphere, part of Bregal Investments, today announced a strategic partnership with Imperative, providing financing to accelerate the development of its global pipeline of high-quality ecosystem restoration projects. As a leading institutional natural capital investor, Bregal Sphere partners with best-in-class developers to deliver large-scale carbon removal projects that generate meaningful impacts for nature, climate, and [...]
InXpress Completes 100,000 Specialist Deliveries as E-Commerce Reshapes Franchise Logistics March 10, 2026 Global franchise network unlocks specialist delivery capabilities through TEG platform integration
C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology March 10, 2026 C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Selected programmes to potentially address multiple children’s cancers including Ewing sarcoma, bone sarcoma, medulloblastoma and acute myeloid leukaemia Additional C-Further programmes to be announced in 2026